ABSTRACT
INTRODUCTION
DJ-1/PARK7 is an ubiquitous, highly conserved protein that was originally identified because of its ability to transform NIH3T3 mouse cells in cooperation with Ras (Nagakubo et al., 1997) . Starting from the association between loss-of-function mutations in * To whom correspondence should be addressed.
the DJ-1 gene and PARK7, a monogenic, autosomal-recessive form of Parkinson's disease (PD) (Bonifati et al., 2003) , an accumulating body of evidence pinpointed the important role of DJ-1 in this neurodegenerative condition. Very recently, it has been shown that oxidized dopamine can covalently modify DJ-1 (Van Laar et al., 2009) ; however, whether this can affect dopamine cell degeneration is unknown. Some hints may come from the involvement of DJ-1 into many cellular functions, including evidence linking this protein to oxidative stress response-a fact well known even before the association of DJ-1 with PD (Mitsumoto et al., 2001 )-mitochondrial function (Zhang et al., 2005) and transcription (Zhong and Xu, 2008) , nuclear transcription (Xu et al., 2005) , mRNA binding and protein interaction (Hod et al., 1999; van der Brug et al., 2008) and protein degradation (Xiong et al., 2009) . Mirroring the involvement of DJ-1 in multiple cellular activities, this protein has been found in complex with multiple molecular partners, including DJ-1 itself (Tao and Tong, 2003) , PINK-1 and Parkin (Xiong et al., 2009) , alpha-synuclein (Meulener et al., 2005) , HSP70 (Li et al., 2005) , DJBP (Niki et al., 2003) , PIASx alpha (Takahashi et al., 2001) , ASK1 (Waak et al., 2009) , histone deacetylase 6 (Olzmann et al., 2007) , androgen receptor (Tillman et al., 2007) , DAXX (Junn et al., 2005) and Abstrakt (Sekito et al., 2005) . DJ-1 has been shown to modulate dopamine toxicity in cellular models of oxidative stress with reference to PD (Fasano et al., 2008) . Dopamine exposure leads to upregulation of DJ-1 that in turn increases cell resistance to dopamine itself and reduces intracellular oxidants (Lev et al., 2008; Lev et al., 2009) . On the other hand, α-synuclein overexpression leads to upregulation of DJ-1, and DJ-1 overexpression protects cells from α-synuclein toxicity (Batelli et al., 2009; Colapinto et al., 2006; Zhou and Freed, 2005) .
Besides being in complex with a number of different partners, DJ-1 is often post-translationally modified. DJ-1 modifications mainly include oxidations at different sites, which is related to its antioxidant role (Choi et al., 2006; Kinumi et al., 2004; Mitsumoto et al., 2001) , but there are also evidences of ubiquitination (Olzmann et al., 2004 (Olzmann et al., , 2007 and SUMOylation (small ubiquitin-like modifier) (Shinbo et al., 2006) .
Not unexpectedly, DJ-1 binding to its molecular counterparts, and thus its pleiotropic effects, are affected by DJ-1 post-translational modification. For example, oxidation regulates homodimerization (Ito et al., 2007) and affects DJ-1 binding to mRNA (van der Brug et al., 2008) , ASK1 (Waak et al., 2009) , HSP70 (Li et al., 2005) , parkin (Moore et al., 2005) , while ubiquitination mediates the binding to histone deacetylase 6 and thus to the dynein-dynactin complex (Olzmann et al., 2007) .
Multiple DJ-1 modified forms are simultaneously present, so that DJ-1 can be better considered as a pool of different forms, with different modifications and in different amounts. It is very likely that, instead of the total amount of DJ-1 or of a defined DJ-1 form, the composition of this pool and the precise balance between different forms is the main factor determining DJ-1 global activity. In particular, alterations of this pool, instead of DJ-1 mutations, are expected to play a role in those non-genetic conditions correlated to DJ-1 activity, including idiopathic PD. Indeed, since many different DJ-1 forms can be separated on the basis of their isoelectric point (pI), it is a common finding that DJ-1 oxidation, correlated to aging, Parkinson's and Alzheimer's diseases, produces an increase in DJ-1 species of acidic pH, and a decrease in basic species, so that these conditions are characterized by a pool of DJ-1 forms different from that observed in controls (Canet-Avilés et al., 2004; Choi et al., 2006; Meulener et al., 2006) . Ubiquitination and SUMOylation of DJ-1, on the other side, affects also the molecular weight (MW) of the modified species, and are thus separated by mono-dimensional electrophoresis accordingly (Olzmann et al., 2004 (Olzmann et al., , 2007 Shinbo et al., 2006) .
While two-dimensional electrophoresis (2-DE) is able in principle to separate DJ-1 modified forms on the basis of both pI and MW changes, to the best of our knowledge there is no experimental evaluation of DJ-1 modifications, which takes into account both dimensions simultaneously, so as to completely describe the pool of DJ-1 possible forms and to evaluate the pool composition in a given condition.
To this purpose, a robust procedure was developed to reevaluate 2-DE experiments available in the literature by automatic alignment. Since detailed information on experimental conditions, protocols and samples was available, it was possible to segregate different DJ-1 forms into pools associated with a defined condition independently by the particular experimental protocols used. Interestingly, the DJ-1 pool from neural tissues, in particular from brain, displayed a specific and characteristic MW and pI pattern. Moreover, changes in this pattern might reflect neurodegenerative processes and aging. These results were experimentally validated by 2-DE western blotting on human post-mortem brain specimens from control subjects and PD patients.
METHODS

Search strategy and 2D-gel data extraction
A set of relevant data to be included into the analysis, i.e. 2D-gel experiments where the protein DJ-1 was clearly identified, was obtained by extracting the relevant 2D-gel images from Pubmed-indexed Portable Document Format documents through July 2009. Briefly, we started by querying Medline for publications indexed with the subject heading DJ-1 or its alias: "PARK7" As of July, 2009, this query identified 474 papers. We then proceed to parsing using Big Faceless Organization software (KSM Ltd, London, UK), so as to extract the figures and the figures captions of the considered papers.
Those figures containing 2D-gel representations were identified by a textmatching procedure, and able to evaluate each caption for the occurrence of at least one term identified as connected to a 2D-gel experiment (for the list of terms used, see Supplementary Table 2 ). This step led to the identification of 53 figures from 37 papers, which were automatically segmented to isolate 160 2D-gel images. The 2D-gel sources included in the analysis are listed in Supplementary Table 2.
2D-gel alignment and 'metagel' production
The 2D-gel images were processed using ImageJ (National Institutes of Health) (Girish and Vijayalakshmi, 2004) , including DJ-1 spots that could not be directly aligned, given the differences in resolution of the original figures and the different pI/MW range represented. Therefore, gel images were rescaled by calibrating the pixel-to-pI ratio using the following factor:
where pix pI was the desired resolution in the final image (i.e. 400 pixels per pI unit), pI B and pI A were the pI values of the center of mass of the most basic and of the most acid spot, respectively, and pI B and pI A the pixel number of the center of mass of the most basic and of the most acid spot, respectively. For MW calibration, the average position of the mass center of the four most intense DJ-1 spots was assumed to correspond to the mass reported for DJ-1.
Once rescaled and registered on the reference pI/MW grid, gel images were background subtracted, segmented for the spots and binarized. To this aim, a rolling-ball procedure was used first (rolling ball radius = 50 pixel, performing a sliding paraboloid), then a watershed segmentation procedure was applied (smooth radius 5.0, dark objects on bright background, neighborhood of 8 pixels, minimum level '0', maximum level '120', display outputs 'binary image') and finally an automatic thresholding to get the binarized image (Pleissner et al., 1999) .
The 160 binarized images were used to get a 'metagel', i.e. an average intensity projection image, wherein each pixel stores the average intensity over all images in the 160 original images at corresponding pixel location (Fig. 1) . The color scale of this metagel accounts for the occurrence frequency of each spot in the considered experiments, with less frequent spot positions in blue and more frequent spot positions in white.
The same approach was used to build two additional 'metagels' which represent all the experiments of Alzheimer's/PD patient brain (n = 11) and all the experiments of control human brain origin (n = 12).
The entire procedure is represented as a flowchart in Supplementary 
'Spot matrix' generation
In order to gain insight on possible correlations between specific spot patterns on 2D-gel experiments and biologically relevant information, an objective matrix was generated to correlate each spot in a given 2D-gel to one of the reference spot of the metagel, i.e. to one of the DJ-1 forms occurring in at least 5% of the considered experiments. Briefly, the following, fully automated procedure was performed: (i) the 'metagel' was segmented as described above for the experimental gels; (ii) the Euclidean distance of the center of mass of each experimental spot from the center of mass of each spot in the 'metagel' was calculated; and (iii) a 'spot matrix' was build, where rows correspond to two dimensional gel (2D-gel) experiments, and columns to the spots in the 'metagel'.
A value of 1 was assigned if the Euclidean distance between any spot of the considered experiment and the 'metagel' spot defining the matrix column was minor or equal to the Feret diameter of the 'metagel' spot (i.e. the considered experiment contains a spot that is covered at least partially by a specific spot of the 'metagel').
The 'spot matrix' so obtained is thus a synthetic representation of the occurrence of each spot, identified in the 'metagel' and corresponding to a form of DJ-1 in a given experiment, allowing the description of each experiment in terms of which DJ-1 forms were present.
Statistics
The spot matrix was analyzed using the software XLSTAT (Addinsoft, Paris, France) as described hereafter.
The co-occurrence of different spots was measured to group those spots which most often are present simultaneously (i.e. to get pools of DJ-1 forms) according to Pearson's correlation method applied row by row in the 'Spot matrix': the linear correlation was measured between the presence of a given spot in a given experiment (expressed by a value of 1 in the corresponding cell of the spot matrix) and the presence of the other spots in the same experiment (expressed by the value, 0 or 1, of the other spots in the same row). The correlation alpha significance threshold to include a spot in a pool was set to 0.01.
Grouping of the considered experiments was achieved by agglomerative hierarchical clustering in order to put together different experiments on the basis of the similarity of their vectorial representation in the 'spot matrix', i.e. on the basis of the occurrence of similar spots. The similarity between experiments was computed as Euclidean distances for each pair of rows in the 'spot matrix'. The Euclidean distances (d) are given for each pair of rows, A = (a 1 , a 2 , ..., a p ) and B = (b 1 , b 2 , ..., b p ), by the equation:
where p is the number of columns/variables (19 in our case). The resulting distance matrix was used to cluster the experiments according to the Ward's method (Ward, 1963) . Here, the clustering criterion is based on the error sum of squares, E, which is defined as the sum of the squared distances of individuals from the center of gravity of the cluster to which they have been assigned. Initially, E is 0, since every individual is in a cluster of its own. At each stage, the link created is the one that makes the least increase to E. Aggregation was stopped by automatic truncation, based on the entropy level, so to get groups as homogeneous as possible.
Human substantia nigra specimens
Specimens of human substantia nigra pars compacta (SNpc) from four patients having known sporadic PD history and from three unaffected controls were provided by the Nederlandse Hersenbank (the Netherland's Brain Bank, NBB), Amsterdam. Each specimen was accompanied by histopathological report, showing depletion of pigmented dopaminergic neurons and the occurrence of extracellular neuromelanin granules as well as Lewy bodies in surviving neurons of the PD patient. Human brain material was obtained via the rapid autopsy system of the NBB that supplies postmortem specimens from clinically well documented and neuropathologically confirmed cases. For the staging of pathological hallmarks, a combination of parameters was applied (Braak et al., 2003; Ravid et al., 1998) . Details are given in Table 1 . Autopsies were performed on donors from whom written informed consent was obtained either from the donor or direct next of kin.
In agreement with Dutch law, no ethics statement is required. All research involving human brain material, however, was conducted according to the ethical declaration of the NBB. Human brain tissue specimens (0.5-0.7 g) were homogenized (20 up-and-down strokes with a Teflon homogenizer followed by five passages through a 22-gauge needle) in 3 µl UTC (7M Urea, 2M Thiourea, 4% CHAPS) lysis solution per mg tissue. After centrifugation at 21 000g for 30 min at 20 • C, supernatants were recovered; protein content was estimated with the Bradford assay.
2D-electrophoresis experiments
Immobilized pH gradients (IPG) strips, IPG buffer, acrylamide and polyvinyldifluoridene membranes were from GE Healthcare, Uppsala, Sweden. The Bradford assay for protein concentration determination was from Bio-Rad Laboratories (Hercules, CA, USA). The chemiluminescence western blotting detection system (SuperSignal West Pico Chemiluminescent) was from Pierce Biotechnology, Inc.
(Rockford, IL, USA). Anti-DJ-1 monoclonal antibody was from Medical and Biological Laboratories, Nagoya, Japan. All other reagents were cell-culture grade from Sigma (St Louis, MO, USA) and were used without further purification. 2-DE was performed according to Jacobs (Jacobs et al., 2001) , with some modifications. Samples (100 µg) were diluted to 250 µl with UTC containing 0.5% immobilized pH gradient (IPG) buffer 3-10, 2 mM tributylphosphine and traces of bromophenol blue, and loaded on 13 cm IPG DryStrips with a non-linear 3-10 pH gradient by in-gel rehydration. Isoelectrofocusing was performed at 22 • C on IPGphor (GE Healthcare) according to the following schedule: 1 h at 0 V, 10 h at 30 V, 1 h at 200 V, 30 min linear gradient to 3500 V, 3 h at 3500 V, 2 h and 30 min of linear gradient to 8000 V and 6 h at 8000 V. Prior to sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE), the IPG strips were equilibrated for 2 × 30 min in 50 mM TrisHCl pH 8.8, 6 M urea, 30% glycerol, 2% SDS and traces of bromophenol blue containing 1% dithiothreitol for the first equilibration step and 2.5% iodoacetamide for the second one. SDS-PAGE was performed using 12.5% polyacrylamide gels without stacking gel with the Hoefer SE 600 system (GE Healthcare).
The second dimension was carried out at 15 mA/gel for 15 min and at 45 mA/gel, at 16 • C, until the bromophenol dye front had migrated to the lower end of the gels. Carbamylated pI and MW markers (GE Healthcare) were used for 2-DE calibration. Gels were transferred to PVDF membranes at 1.5 mA/cm 2 for 1 h, 4 • C.
Membranes were saturated in 5% bovine serum albumin (BSA) in tris buffered saline and tween (TBS-T) (0.5 M Tris, pH 7.4, 2 M NaCl and 0.1% Tween-20) and incubated with anti-DJ-1 monoclonal antibody (1 µg/ml in 1% BSA TBS-T) for 1 h at room temperature. Membranes were then washed with TBS-T and incubated with peroxidase-conjugated anti-mouse-IgG antibody (1:80000 in 1% BSA TBS-T) for chemiluminescence detection. Figure 1 reports the distribution of all the DJ-1 major forms represented in the scientific literature considered in the present work. From this Figure, it becomes immediately evident that the protein was reported with different MWs (20 and 25 kDa).
RESULTS
Two pools of DJ-1 forms are alternatively present
Correlated DJ-1 forms (i.e. DJ-1 forms that appear together in different experiments) were identified by building the correlation matrix reported in Figure 2A , where the cells of the matrix are colored according to the Pearson's correlation coefficient of the corresponding spot pair (see Section 2). Two groups of spots are positively correlated: a first group, including spots 4, 5, 6, 7, 8, and a second group, including spots 12, 13, 14, 15, 16, 17. Out of 160 experiments considered in the present work, 68 contained at least one spot of the correlation group 1, and 54 contained at least one spot from correlation group 2. The spots in the two groups are separated on the basis of the apparent MW, because the first group includes only DJ-1 forms with MW ≈ 25 kDa, while in the second group only forms with MW ≈ 20 kDa are present. Therefore, DJ-1 appears either at the expected MW (MW ≈ 20 kDa) or as an heavier, modified form. The latter cannot be explained by a different sequence, since all the species considered in the present study (human, mouse, ovine and bovine) express a protein of predicted MW ≈ 20 kDa. Moreover, DJ-1 forms with MW ≈ 25 kDa are widely represented in the considered papers, and therefore they are not correlated with a particular protocol or a particular laboratory.
The existence of a 25 kDa DJ-1 form is documented in the literature also by a number of one-dimensional western blot experiments. For example, human DJ-1 of a similar MW appears in the works of Shinbo (Shinbo et al., 2006) and Bieler (Bieler et al., 2009) , and in rat a similarly heavier DJ-1 was observed in the work of Yanagida (Yanagida et al., 2006) . Further support to the existence of a heavier form of DJ-1 comes from the one-dimensional western blot reported as quality control by DJ-1 commercial antibody manufacturers (Supplementary Table 3 ). Again, it appears that, independently from the particular antibody used, the protein appears alternatively as a 25 kDa or 20 kDa band. Like the MW, the pI of the two identified pools is also different. The average pI of the 25 kDa pool tends to be more basic, if compared with the average pI of the 20 kDa pool, so that the increase in MW appears to be correlated to a corresponding increase in pI.
Interestingly, spots that are positively correlated in one group tend to be negatively correlated with the spots of the other group, so that the two identified pools are mutually exclusive. This fact could be due to at least one kind of post-translational modification of DJ-1, changing the mass of the protein, which acts like an alternative switch. The functional meaning of this switch will be investigated in future studies.
DJ-1 patterns in 2D-gel experiments are reminiscent of the tissutal origin of the sample
To ascertain whether the identified pools have any biological relevance, all the experiments (i.e. all the 2-DE patterns) were grouped according to their similarity in terms of Euclidean distances between the corresponding rows in the 'spot matrix', and then the experiments were aggregated on the basis of the described procedure. The resulting dendrogram is reported in Figure 3 . Most of the experiments segregates into two groups: one contains mainly 2-DE gels from 'human, brain' samples (cluster 2, including neural cell lines), while the other contains experiments of heterogeneous, mostly non-neural and/or non-human origin (cluster 1). Moreover, there is a separate 'non-neural' cluster (cluster 3), which contains experiments coming from a single paper, with an overall DJ-1 pattern not supported by any other paper and consequently suspicious of experimental biases. For this reason, we did not consider this cluster further. Interestingly, the 'human, neural' cluster 2 contains only three samples originating from cellular lines (dopaminergic neuroblastoma M17 line), while all the other 23 experiments in this cluster are 2-DE conducted on proteins from human brain.
Once the experiments were grouped, it was possible to verify whether the clusters formed on the basis of the similarity between the images could be supported also by some non-biological bias (such as the paper of origin of the images, the authors of the experiments and the particular protocol used). The latter hypothesis would imply either that the results are strongly dependent on the particular author presenting them (i.e. they are not reproduced by others) or they are extremely sensitive to the experimental conditions used (i.e. they are not reproducible). Beside the aforementioned bias in cluster 3, both clusters 1 and 2 contain experiments from different papers, with different staining procedures, so that neither of these bias factors could explain the different DJ-1 patterns responsible for the observed clustering.
Therefore, it is possible to distinguish, at least in humans, the brain origin of DJ-1 on the basis of its 2-DE pattern, i.e. there is a specific experimental pattern associated with DJ-1 of human brain origin.
The pool containing lighter, more acidic forms of DJ-1 is prevalent in neural tissues
We further proceeded to verify whether the 2-DE gel patterns responsible for clusterization in Figure 3 corresponded to the pools of correlated DJ-1 forms identified in Figure 2 . Interestingly, all the experiments included in cluster 2 contained spots from correlation group 2, characterized by a MW ≈ 20 kDa and a more acid average pI (see Fig. 2B ); moreover, none of these experiments contained any spot from correlation group 1 (MW ≈ 25 kDa). Conversely, all the experiments included in cluster 1 contained spots from correlation group 1, which has a MW ≈ 25 kDa and does not contain any spot of MW ≈ 20 kDa. Since cluster 2 groups together with experiments on human brain samples, there is a pool of DJ-1 isoforms, identified in Figure 2B as group 2, that is typical of neural samples and particularly of DJ-1 from brain. Thus, it appears that the posttranslational modification responsible for the 25 kDa forms is at best only marginally active in most of the samples of human brain origin.
Meta-analysis of DJ-1 modifications induced by neurodegeneration and aging
To check whether any described modification of the DJ-1 pool associated with neurodegeneration could be supported by our meta-analysis, a metagel obtained by all documented experiments on control human brains (12 experiments) was compared with the corresponding metagel obtained from patients with neurodegenerative conditions (11 experiments) ( Figure 4A and B, respectively). According to the source literature, these experiments are representative of the DJ-1 status in 53 control brains (33 healthy, 20 astrocytoma) and 70 brains from individuals showing neurodegenerative condition (30 PD, 11 Alzheimer's disease, 13 progressive supranuclear palsy, 4 corticobasal degeneration and 12 frontotemporal lobar degeneration). Human brain tissues display a subset of DJ-1 forms that correlate with the occurrence of neurodegenerative processes, including PD. In particular, the frequency of acid forms increases, while the frequency of more basic forms decreases. Noteworthy, if a single individual is considered, no specific form of DJ-1 could be connected to any neurodegenerative condition. On the contrary, the data reported herein are referred to the overall patient population, considered in the source literature. These findings are expected on the basis of a specific accumulation of DJ-1 acidic forms in the brain of Parkinson's and Alzheimer's disease patients, mentioned originally by Bandopadhyay and coworkers (Bandopadhyay et al., 2004) . Indeed, 10 different DJ-1 forms, including the acidic forms (pI 5.5 and 5.7) of 20 kDa DJ-1 were observed to be selectively accumulated in frontal cortex of patients compared with age-matched controls (Choi et al., 2006) .
In order to take into account the role of aging, we considered a couple of DJ-1 patterns from the brains of two old subjects (age = 92 and 98, respectively) (Meulener et al., 2006) . Also in this case, the literature hypothesis is confirmed, in that both subjects possess a DJ-1 pool similar to that of PD patients, thus suggesting an accumulation of oxidized, acidic forms of the protein, which is related to aging, similar to that observed in PD patients.
Occurrence of specific DJ-1 forms associated with neurodegeneration is confirmed by western blot analysis of post-mortem specimens of human substantia nigra
The meta-analysis so far described led us to predict that: (i) the pool of DJ-1 forms in brain tends to have a weight of ∼20 kDa; (ii) PD patients are expected to have an unbalance toward more acidic forms of the protein, as previously found in literature.
To experimentally verify this prediction, anti-DJ-1 immunoblots for three controls and three PD patients were performed. Among them, two were clinically and histopathologically negative for PD diagnosis, whereas one of the control subjects showed histological evidence of mild degeneration although he was clinically healthy (CO280). Three patients were included in the PD group after careful evaluation of clinical history and neuropathological report.
Two metagels were built for control cases and PD subjects ( Figure 4C and D, respectively). Only 20 kDa species were detected in both metagels, confirming the predominance of this form in the brain. For all extracts, three main DJ-1 forms are observed at pI = 5.8, 6.1 and 6.4. Despite the limited number of cases, due to difficulty in obtaining human post-mortem samples of substantia nigra, even in the small population considered, there is some tendency toward more acidic forms into the PD subjects (arrows in Figure 4C and D) .
A confounding factor is due to the inclusion in the control group of CO280. The DJ-1 pattern of this subject is different from other controls, showing the same acidic forms observed in PD subjects, and rendering the control metagel somehow more similar to the PD metagel. Remarkably, this 'control' appears positive for the presence in its brain of tangles (Table 1) , a typical hallmark of oxidative stress and damage in brain, although Lewy bodies were not observed. DJ-1 pool modification in this subject might thus be related to some form of brain damage, without clinical symptoms.
More specimens would be needed to confirm the outlined picture of the modifications of DJ-1 under PD, nevertheless it should be noted here that the reported pattern is sustained by a number of publications in a larger population, as previously outlined. Although we could imagine that in SNpc pf PD patients dopaminergic neurons are mainly lost, DJ-1 oxidative modifications witness the occurrence of oxidative stress conditions in the affected area, either it comes from residual neurons or from astrocytes.
DISCUSSION AND CONCLUSIONS
The meta-analysis of proteomic data can provide valuable information pertinent to various biological processes (or methods involved) that otherwise remains hidden if a single paper is considered. The occurrence of frequently identified proteins, for instance, may represent common cellular stress responses or simply reflect technical limitations of 2-DE, as recently stated by Petrak and coworkers in their visionary paper on déjà-vu in proteomic reports (Petrak et al., 2008) . We developed therefore an innovative procedure to examine the status of DJ-1, a protein extensively and heterogeneously modified, by comparing its 2-DE pattern documented in 160 experiments from 37 different papers. Despite the presence of many different forms of the protein, with different pI and MW, it was found that DJ-1 main forms consistently associated with two different pools, with a different MW and average pI. These two pools are mutually exclusive, and the pool with a MW ≈ 20 kDa and a more acid average pI exhibits strong tissue specificity for brain and neural models. Moreover, we could show that this pool is indeed found experimentally in the SNpc of both PD patients and control subjects and, in agreement with the previous literature, there is a tendency at the level of population toward more acid forms in PD patients.
Altogether, these findings support the value of a proteomic metaanalysis for the unraveling of complex proteomic signatures and biomarker analysis.
